Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?
- PMID: 30669417
- PMCID: PMC6357097
- DOI: 10.3390/cancers11010112
Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?
Abstract
Radiotherapy is a mainstay treatment for many types of cancer and kills cancer cells via generation of reactive oxygen species (ROS). Incorporating radiation with pharmacological ROS inducers, therefore, has been widely investigated as an approach to enhance aerobic radiosensitization. However, this strategy was overlooked in hypoxic counterpart, one of the most important causes of radiotherapy failure, due to the notion that hypoxic cells are immune to ROS insults because of the shortage of ROS substrate oxygen. Paradoxically, evidence reveals that ROS are produced more in hypoxic than normoxic cells and serve as signaling molecules that render cells adaptive to hypoxia. As a result, hypoxic tumor cells heavily rely on antioxidant systems to sustain the ROS homeostasis. Thereby, they become sensitive to insults that impair the ROS detoxification network, which has been verified in diverse models with or without radiation. Of note, hypoxic radioresistance has been overviewed in different contexts. To the best of our knowledge, this review is the first to systemically summarize the interplay among radiation, hypoxia, and ROS, and to discuss whether perturbation of ROS homeostasis could provide a new avenue to tackle hypoxic radioresistance.
Keywords: hypoxia; radiation; radiosensitization; reactive oxygen species.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.ACS Nano. 2017 Jul 25;11(7):7164-7176. doi: 10.1021/acsnano.7b03037. Epub 2017 Jun 26. ACS Nano. 2017. PMID: 28640996
-
Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation.Theranostics. 2018 Nov 12;8(21):5870-5889. doi: 10.7150/thno.27351. eCollection 2018. Theranostics. 2018. PMID: 30613268 Free PMC article.
-
The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia.Front Oncol. 2018 May 25;8:170. doi: 10.3389/fonc.2018.00170. eCollection 2018. Front Oncol. 2018. PMID: 29888201 Free PMC article.
-
Targeting antioxidant enzymes as a radiosensitizing strategy.Cancer Lett. 2018 Dec 1;438:154-164. doi: 10.1016/j.canlet.2018.09.004. Epub 2018 Sep 14. Cancer Lett. 2018. PMID: 30223069 Review.
-
Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy.Antioxidants (Basel). 2022 May 7;11(5):921. doi: 10.3390/antiox11050921. Antioxidants (Basel). 2022. PMID: 35624785 Free PMC article. Review.
Cited by
-
Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.Cell Death Discov. 2020 Aug 18;6:77. doi: 10.1038/s41420-020-00311-0. eCollection 2020. Cell Death Discov. 2020. PMID: 32864165 Free PMC article. Review.
-
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers.Cancers (Basel). 2022 Oct 15;14(20):5054. doi: 10.3390/cancers14205054. Cancers (Basel). 2022. PMID: 36291840 Free PMC article. Review.
-
The Effect of Low Temperatures on Environmental Radiation Damage in Living Systems: Does Hypothermia Show Promise for Space Travel?Int J Mol Sci. 2020 Sep 1;21(17):6349. doi: 10.3390/ijms21176349. Int J Mol Sci. 2020. PMID: 32882991 Free PMC article. Review.
-
Positive Aspects of Oxidative Stress at Different Levels of the Human Body: A Review.Antioxidants (Basel). 2022 Mar 17;11(3):572. doi: 10.3390/antiox11030572. Antioxidants (Basel). 2022. PMID: 35326222 Free PMC article. Review.
-
Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas.Molecules. 2021 Feb 22;26(4):1169. doi: 10.3390/molecules26041169. Molecules. 2021. PMID: 33671796 Free PMC article. Review.
References
-
- Ogata T., Teshima T., Kagawa K., Hishikawa Y., Takahashi Y., Kawaguchi A., Suzumoto Y., Nojima K., Furusawa Y., Matsuura N. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005;65:113–120. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials